bg-title

Zedler B, Xie LWang L, Joyce A, Vick C, Brigham J, Kariburyo MF, Baser O, Murrelle L. Development of a risk index for serious prescription opioid-induced respiratory depression or overdose in Veterans’ Health Administration patients. Pain Med. 2015;16(8):1566-79.

Aktaş B, Coban S, Altinbaş A, Başer O. Eosinophilic gastroenteritis associated with allergic asthma and atopic eczema. Chin Med J (Engl). 2014;127(1):192.

Rank MA, Shah ND. Multiple chronic conditions and asthma: implications for practice and research. J Allergy Clin Immunol Pract. 2014;2(5):518-24.

Akin C, Valent P. Diagnostic criteria and classification of mastocytosis in 2014. Immunol Allergy Clin North Am. 2014;34(2):207-18.

Fried AJ, Akin C. Primary mast cell disorders in children. Curr Allergy Asthma Rep. 2013;13(6):693-701.

Lee MJ, Akin C. Mast cell activation syndromes. Ann Allergy Asthma Immunol. 2013;111(1):5-8.

Rank MA, Ziegenfuss JY, Shah KM, Jenkins SM, Lackore KA, Eton DT, Shah ND. Factors associated with decisions to step down asthma medications. J Allergy Clin Immunol: In Practice. 2013;1(3):312-4.

Baser O. Generalized propensity score matching with multilevel treatment options. JHEOR. 2013;1(1):1-13.

Rank MA, Liesinger JT, Ziegenfuss JY, Branda ME, Lim KG, Yawn BP, Li JT, Shah ND. Asthma expenditures in the United States comparing 2004 to 2006 and 1996 to 1998. Am J Manag Care. 2012;18(9):499-504.

Rank MA, Liesinger JT, Ziegenfuss JY, Branda ME, Lim KG, Yawn BP, Shah ND. The impact of asthma medication guidelines on asthma controller use and on asthma exacerbation rates comparing 1997-1998 and 2004-2005. Ann Allergy Asthma Immunol. 2012;108(1):9-13.

Simsek H,Pinar A, Altinbas A, Alp A, Balaban YH, Buyukasik Y, Ozcebe O, Hascelik G, Gedikoglu G, Tatar G. Cutoff level to detect heterozygous alpha 1 antitrypsin deficiency in Turkish population. J Clin Lab Anal. 2011;25(4):296-9.

Lim KG, Rank MA, Li JT, Patel A, Volcheck GW, Branda ME, Cabanela R, Naessens JM, Shah ND, et al. How well does patient self-report predict asthma medication possession? Implications for medication reconciliation and adherence assessment. J Asthma. 2010;47(8):878-82.

Akin C. Anaphylaxis and mast cell disease. What is the risk? Curr Allergy Asthma Rep. 2010;10:34–38.

Altinbaş A, Arik G, Kalyoncu U, Akdoğan A, Karadağ O, Kisacik B, Ertenli AI. Successful treatment of primary Sjögren's syndrome complicated with primary biliary cirrhosis and lung involvement. Turk J Gastroenterol. 2010;21(1):60-2.

Baser O. Choosing propensity score matching over regression adjustment for causal inference: when, why and how it makes sense. J Med Econ. 2007;10:379-91.

Baser O. Too much ado about propensity score models? Comparing the methods of propensity score matching. Value Health. 2006;9(6):377-85.

Baser O, Crown WH, Pollicino C.  Guidelines for selecting among different types of bootstraps. Curr Med Res Opin. 2006;22(4):799-808.

Ozminkowski R, Goetzel R, Shechter D, Stapleton CD, Baser O, Lapin PJ. Predictors of preventive service’s use among medicare beneficiaries. Health Care Financ Rev. 2006;27(3):5-23.

Crown WH, Berndt ER, Baser O, et al. Benefit plan design and prescription drug utilization among asthmatics: Do patient copayments matter? Front Health Policy Res. 2004;7:95-127.

To request article copies, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it..